Medications for Liposarcoma

5 results

  • Eribulin mesylate (eribulin mesylate)

    (Eribulin Mesylate)
    Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
    Usage: Eribulin mesylate injection is indicated for treating metastatic breast cancer in patients who have received at least two prior chemotherapeutic regimens, including an anthracycline and a taxane. It is also used for unresectable or metastatic liposarcoma in those who have received a prior anthracycline-containing regimen.

  • Eribulin mesylate (eribulin mesylate)

    (eribulin mesylate)
    Apotex Corp.
    Usage: Eribulin mesylate injection is indicated for treating metastatic breast cancer in patients who have undergone at least two prior chemotherapy regimens, including anthracycline and taxane, and for unresectable or metastatic liposarcoma following an anthracycline-containing regimen.

  • Eribulin mesylate (eribulin mesylate)

    (Eribulin Mesylate)
    Baxter Healthcare Corporation
    Usage: Eribulin Mesylate Injection is indicated for treating metastatic breast cancer in patients who have received at least two prior chemotherapy regimens, including an anthracycline and a taxane. It is also indicated for unresectable or metastatic liposarcoma in patients previously treated with an anthracycline-containing regimen.

  • Halaven

    (eribulin mesylate)
    Eisai Inc.
    Usage: HALAVEN is indicated for treating metastatic breast cancer in patients who have received at least two prior chemotherapy regimens, including anthracyclines and taxanes, and for unresectable or metastatic liposarcoma in patients previously treated with an anthracycline-containing regimen.

  • Yondelis

    (Trabectedin)
    Janssen Products, LP
    Usage: YONDELIS® is indicated for treating patients with unresectable or metastatic liposarcoma or leiomyosarcoma who have previously received an anthracycline-containing regimen.